Discontinuation of statins for primary prevention of atherosclerotic cardiovascular disease in adults aged 75 years or older (SAGA/SITE): a multicentre, open-label, pragmatic, non-inferiority randomised trial
Fabrice Bonnet, Pierre Poulizac, Nicolas Rousselot, Thierry Couffinhal et autres
BACKGROUND: Statins are among the most widely used drugs; however, their benefits for primary prevention of atherosclerotic cardiovascular disease (ASCVD) in individuals aged 75 years or older without the disease remain uncertain. We aimed to assess the non-inferiority of statin cessation in …
fr (code pays fourni par la source)
0 citations
The Lancet Healthy Longevity